» Articles » PMID: 37004079

Global Health Governance Performance During Covid-19, What Needs to Be Changed? a Delphi Survey Study

Overview
Journal Global Health
Publisher Biomed Central
Date 2023 Apr 2
PMID 37004079
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Covid-19 is not the first pandemic to challenge GHG. Preceding outbreaks and epidemics were sources of continuous debate on GHG leadership and structure resulting in its current structure. However, Covid-19 proved the presence of many deficits in the current GHG. The response to the Covid-19 pandemic is a cumulative result of all policies and actions of different governments and agencies active in global health. Assessing how Covid-19 is being handled globally provides lessons for ensuring better performance in facing upcoming outbreaks. This study has three main objectives: first, to evaluate the performance of GHG during Covid-19 in general and in relation to Covid-19 vaccine equity in particular. Second, to identify the reasons behind this performance; and third, to propose prospective changes in GHG for better performance.

Methods: A cross-sectional research design using the Delphi method was applied. A panel of experts participated in the three-round Delphi surveys. Their scores were used to perform consensus, performance and correlation analysis.

Results: GHG performance limited the achievement of Covid-19 vaccines' global equity. GHG performance is a product of the existing GHG system, its actors and legal framework. It is a collective result of individual GHG actors' performance. The most influential actors in decision-making regarding Covid-19 vaccine are the vaccine manufacturers and governments. While the most invoked power to influence decision are economic and political powers. Covid-19 decisions underlying value, although had human right to health at the base, overlooked the concept of health as a global public good and was skewed towards market-oriented values. GHG mal-performance along with its underlying factors calls for four main changes in GHG structure: assigning a clear steward for GHG, enhanced accountability, centralized authority, more equitable representation of actors, and better legal framework.

Conclusion: GHG structure, actors' representation, accountability system, and underlying priorities and value require future modification for GHG to achieve better future performance and higher health equity levels.

Citing Articles

Integrating animal welfare into the WHO pandemic treaty: a thematic analysis of civil society perspectives and comparison with treaty drafting.

Huang Y, Jiang S, Daminova N, Kumah E Front Vet Sci. 2024; 11:1421158.

PMID: 39606645 PMC: 11599984. DOI: 10.3389/fvets.2024.1421158.


COVID-19 vaccine intercountry distribution inequality and its underlying factors: a combined concentration index analysis and multiple linear regression analysis.

Abu El Kheir-Mataria W, Khadr Z, El Fawal H, Chun S Front Public Health. 2024; 12:1348088.

PMID: 38577285 PMC: 10993910. DOI: 10.3389/fpubh.2024.1348088.


Co-Occurrence Analysis of COVID-19 Publications with an Emphasis on the Global Health Governance (GHG).

Allahbakhshian Farsani L, Riahinia N, Danesh F, Azimi A Adv Biomed Res. 2024; 13:10.

PMID: 38525400 PMC: 10958719. DOI: 10.4103/abr.abr_344_23.


China and the WHO pandemic treaty: a dive into stance, underpinnings, and implications.

Huang Y, Jiang S, Kumah E Front Public Health. 2024; 12:1335751.

PMID: 38356946 PMC: 10865500. DOI: 10.3389/fpubh.2024.1335751.


Strategizing global health governance: unpacking opportunities and challenges for least developed nations within the WHO pandemic treaty framework.

Jiang S, Kumah E Front Public Health. 2023; 11:1321125.

PMID: 38026386 PMC: 10657804. DOI: 10.3389/fpubh.2023.1321125.


References
1.
Li Z, Lu J, Lv J . The Inefficient and Unjust Global Distribution of COVID-19 Vaccines: From a Perspective of Critical Global Justice. Inquiry. 2021; 58:469580211060992. PMC: 8649905. DOI: 10.1177/00469580211060992. View

2.
Crawford I, Mackway-Jones K, Russell D, Carley S . Delphi based consensus study into planning for chemical incidents. Emerg Med J. 2004; 21(1):24-8. PMC: 1756368. DOI: 10.1136/emj.2003.003087. View

3.
Abu El Kheir-Mataria W, El-Fawal H, Bhuiyan S, Chun S . Global Health Governance and Health Equity in the Context of COVID-19: A Scoping Review. Healthcare (Basel). 2022; 10(3). PMC: 8949542. DOI: 10.3390/healthcare10030540. View

4.
Devi S . Fears of "highly catastrophic" COVID-19 spread in Yemen. Lancet. 2020; 395(10238):1683. PMC: 7255709. DOI: 10.1016/S0140-6736(20)31235-6. View

5.
Kickbusch I, Reddy K . Global health governance - the next political revolution. Public Health. 2015; 129(7):838-42. DOI: 10.1016/j.puhe.2015.04.014. View